• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗SARS-CoV-2抗体识别的表位的结构和功能图谱绘制方法概述。

An overview of methods for the structural and functional mapping of epitopes recognized by anti-SARS-CoV-2 antibodies.

作者信息

Francino-Urdaniz Irene M, Whitehead Timothy A

机构信息

Department of Chemical and Biological Engineering, University of Colorado JSC Biotechnology Building, 3415 Colorado Avenue Boulder CO 80305 USA

出版信息

RSC Chem Biol. 2021 Sep 29;2(6):1580-1589. doi: 10.1039/d1cb00169h. eCollection 2021 Dec 2.

DOI:10.1039/d1cb00169h
PMID:34977572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8637828/
Abstract

This mini-review presents a critical survey of techniques used for epitope mapping on the SARS-CoV-2 Spike protein. The sequence and structures for common neutralizing and non-neutralizing epitopes on the Spike protein are described as determined by X-ray crystallography, electron microscopy and linear peptide epitope mapping, among other methods. An additional focus of this mini-review is an analytical appraisal of different deep mutational scanning workflows for conformational epitope mapping and identification of mutants on the Spike protein which escape antibody neutralization. Such a focus is necessary as a critical review of deep mutational scanning for conformational epitope mapping has not been published. A perspective is presented on the use of different epitope determination methods for development of broadly potent antibody therapies and vaccines against SARS-CoV-2.

摘要

本综述对用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白表位作图的技术进行了批判性审视。除其他方法外,还描述了通过X射线晶体学、电子显微镜和线性肽表位作图确定的刺突蛋白上常见中和及非中和表位的序列和结构。本综述的另一个重点是对不同深度突变扫描工作流程进行分析评估,以用于构象表位作图以及鉴定刺突蛋白上逃避抗体中和的突变体。由于尚未发表对用于构象表位作图的深度突变扫描的批判性综述,因此有必要进行这样的重点研究。本文还就使用不同表位测定方法开发针对SARS-CoV-2的广泛有效的抗体疗法和疫苗提出了观点。

相似文献

1
An overview of methods for the structural and functional mapping of epitopes recognized by anti-SARS-CoV-2 antibodies.抗SARS-CoV-2抗体识别的表位的结构和功能图谱绘制方法概述。
RSC Chem Biol. 2021 Sep 29;2(6):1580-1589. doi: 10.1039/d1cb00169h. eCollection 2021 Dec 2.
2
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting.通过生物信息学和单克隆抗体靶向技术鉴定针对 SARS-CoV-2 刺突蛋白的中和抗体的 B 细胞表位。
Int J Mol Sci. 2022 Apr 14;23(8):4341. doi: 10.3390/ijms23084341.
3
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
4
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.受体结合域和 N 端结构域中和抗体的联合应用限制了 SARS-CoV-2 刺突蛋白中和逃逸突变体的产生。
mBio. 2021 Oct 26;12(5):e0247321. doi: 10.1128/mBio.02473-21. Epub 2021 Oct 5.
5
Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.抗体介导的协同作用以及在刺突蛋白上一个表位簇处对严重急性呼吸综合征冠状病毒中和作用的干扰
Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60. doi: 10.1016/j.bbrc.2009.10.115. Epub 2009 Oct 25.
6
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.SARS-CoV-2 抗体的结构研究鉴定出一种广谱抗体,通过分解 Spike 三聚体来中和奥密克戎变体。
J Virol. 2022 Aug 24;96(16):e0048022. doi: 10.1128/jvi.00480-22. Epub 2022 Aug 4.
7
Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.不同的靶向 L1 蛋白共同脆弱位点的鼠源抗体对痘苗病毒的中和作用。
J Virol. 2014 Oct;88(19):11339-55. doi: 10.1128/JVI.01491-14. Epub 2014 Jul 16.
8
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.靶向 Spike 受体结合域类五隐匿表位的具有泛沙贝科病毒活性的抗体。
J Virol. 2023 Jul 27;97(7):e0159622. doi: 10.1128/jvi.01596-22. Epub 2023 Jul 3.
9
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine.在基于多表位的疫苗中,非中和表位掩盖了针对奥密克戎的中和表位。
ACS Infect Dis. 2022 Dec 9;8(12):2586-2593. doi: 10.1021/acsinfecdis.2c00488. Epub 2022 Nov 10.
10
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen.表位分析揭示了基于 SARS-CoV-2 RBD 的抗原中的关键抗原决定簇。
Front Immunol. 2021 Sep 21;12:707977. doi: 10.3389/fimmu.2021.707977. eCollection 2021.

引用本文的文献

1
Engineering a recombinant VP2-Based neutralizing epitope vaccine candidate against canine parvovirus: a preliminary immunogenicity assessment.构建一种基于重组VP2的犬细小病毒中和表位疫苗候选物:初步免疫原性评估。
Vet Res Commun. 2025 Sep 5;49(5):298. doi: 10.1007/s11259-025-10877-8.
2
Mass Spectrometry-Driven Epitope Mapping: Application of Diethylpyrocarbonate Covalent Labeling for the Immunotherapeutic Target Programmed Cell Death Protein 1.质谱驱动的表位作图:焦碳酸二乙酯共价标记在免疫治疗靶点程序性细胞死亡蛋白1中的应用
J Am Soc Mass Spectrom. 2025 Jul 2;36(7):1480-1492. doi: 10.1021/jasms.5c00070. Epub 2025 Jun 20.
3

本文引用的文献

1
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses.配对的重链和轻链特征有助于公共抗体反应中对 SARS-CoV-2 的有效中和。
Cell Rep. 2021 Oct 5;37(1):109771. doi: 10.1016/j.celrep.2021.109771. Epub 2021 Sep 28.
2
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.利用酵母筛选一次性鉴定严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域逃逸突变体
Cell Rep. 2021 Aug 31;36(9):109627. doi: 10.1016/j.celrep.2021.109627. Epub 2021 Aug 10.
3
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Establishing correlation between in vitro potency and in vivo immunogenicity for mRNA vaccines.
建立mRNA疫苗的体外效力与体内免疫原性之间的相关性。
NPJ Vaccines. 2025 Jun 11;10(1):120. doi: 10.1038/s41541-025-01181-2.
4
Epitope mapping via in vitro deep mutational scanning methods and its applications.通过体外深度突变扫描方法进行的表位作图及其应用
J Biol Chem. 2025 Jan;301(1):108072. doi: 10.1016/j.jbc.2024.108072. Epub 2024 Dec 14.
5
Infrared Spectral Patterns of Thyroglobulin Bearing Thyroiditogenic Epitopes.携带甲状腺致炎表位的甲状腺球蛋白的红外光谱模式。
Protein J. 2025 Feb;44(1):68-78. doi: 10.1007/s10930-024-10243-8. Epub 2024 Dec 4.
6
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges.用于癌症治疗的下一代治疗性抗体:进展、应用与挑战
Mol Biotechnol. 2024 Sep 2. doi: 10.1007/s12033-024-01270-y.
7
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2.接种疫苗的患者和新冠康复者体内产生的天然抗体可识别并水解与新冠病毒S蛋白相对应的寡肽。
Vaccines (Basel). 2023 Sep 15;11(9):1494. doi: 10.3390/vaccines11091494.
8
Hydrogen-Deuterium Exchange Epitope Mapping of Glycosylated Epitopes Enabled by Online Immobilized Glycosidase.在线固定化糖苷酶实现糖基化表位的氢氘交换表位作图
Anal Chem. 2023 Jul 11;95(27):10204-10210. doi: 10.1021/acs.analchem.3c00374. Epub 2023 Jun 28.
9
Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology.理解与调控抗体精细特异性:来自组合生物学的经验教训。
Antibodies (Basel). 2022 Jul 14;11(3):48. doi: 10.3390/antib11030048.
单克隆抗体组合药物 REGEN-COV 可预防 SARS-CoV-2 突变逃逸,这一结论在临床前和人体研究中得到验证。
Cell. 2021 Jul 22;184(15):3949-3961.e11. doi: 10.1016/j.cell.2021.06.002. Epub 2021 Jun 5.
4
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.一种广泛结合 Spike 蛋白的 SARS-CoV-2 中和抗体,并进行了修饰以获得最佳治疗效果。
Nat Commun. 2021 May 11;12(1):2623. doi: 10.1038/s41467-021-22926-2.
5
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.SARS-CoV-2 中和抗体的新型结合表位的结构基础。
PLoS Biol. 2021 May 7;19(5):e3001209. doi: 10.1371/journal.pbio.3001209. eCollection 2021 May.
6
Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy.使用竞争性噬菌体生物淘选策略分离针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域的人单克隆抗体。
Antib Ther. 2020 Apr 30;3(2):95-100. doi: 10.1093/abt/tbaa008. eCollection 2020 Apr.
7
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.逃避单克隆抗体LY-CoV555及其与LY-CoV016的鸡尾酒疗法的SARS-CoV-2受体结合域突变的完整图谱。
Cell Rep Med. 2021 Apr 20;2(4):100255. doi: 10.1016/j.xcrm.2021.100255. Epub 2021 Apr 5.
8
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.中和抗体LY-CoV555可保护非人类灵长类动物免受SARS-CoV-2感染。
Sci Transl Med. 2021 May 12;13(593). doi: 10.1126/scitranslmed.abf1906. Epub 2021 Apr 5.
9
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.针对刺突 N 端结构域的强效 SARS-CoV-2 中和抗体靶向单一超位点。
Cell Host Microbe. 2021 May 12;29(5):819-833.e7. doi: 10.1016/j.chom.2021.03.005. Epub 2021 Mar 12.
10
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.N 端结构域抗原性分析揭示了 SARS-CoV-2 的一个弱点。
Cell. 2021 Apr 29;184(9):2332-2347.e16. doi: 10.1016/j.cell.2021.03.028. Epub 2021 Mar 16.